Japanese cedar tree pollen Allergy Immunotherapy Tablet: Phase II/III data
A double-blind, Japanese Phase II/III in about 1,000 patients with Japanese cedar tree pollen-induced allergic rhinitis showed that sublingual TO-206 met the primary endpoint of improving TCRS vs. placebo. TO-206 was well tolerated. ALK-Abello said...
